HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Robert Hoerr Selected Research

Ginkgo biloba extract (Rokan)

1/2018Treatment effects of Ginkgo biloba extract EGb 761® on the spectrum of behavioral and psychological symptoms of dementia: meta-analysis of randomized controlled trials.
1/2018Ginkgo biloba extract EGb 761® alleviates neurosensory symptoms in patients with dementia: a meta-analysis of treatment effects on tinnitus and dizziness in randomized, placebo-controlled trials.
4/2016A retrospective classification of diagnoses in terms of DSM-5 for patients included in randomized controlled trials of Ginkgo biloba extract EGb 761(®).
1/2014Treatment of Vertigo: A Randomized, Double-Blind Trial Comparing Efficacy and Safety of Ginkgo biloba Extract EGb 761 and Betahistine.
6/2012Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg.
11/2011Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial.
1/2011Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761. Findings from a randomized controlled trial.
12/2005A randomized, double-blind, placebo-controlled trial of two doses of Ginkgo biloba extract in dementia of the Alzheimer's type.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Robert Hoerr Research Topics

Disease

8Dementia (Dementias)
01/2018 - 01/2002
2Dizziness (Lightheadedness)
01/2018 - 06/2012
2Tinnitus
01/2018 - 06/2012
2Cognitive Dysfunction
04/2016 - 12/2005
2Alzheimer Disease (Alzheimer's Disease)
06/2012 - 11/2011
1Hemorrhage
12/2021
1Neurocognitive Disorders (Clerambault Syndrome)
04/2016
1Vertigo (Positional Vertigo)
01/2014
1Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy)
06/2012

Drug/Important Bio-Agent (IBA)

8Ginkgo biloba extract (Rokan)IBA
01/2018 - 12/2005
1Ginkgo ExtractIBA
12/2021
1Betahistine (Serc)IBA
01/2014
1Psychotropic Drugs (Psychoactive Drugs)IBA
12/2005
1EnsaculinIBA
01/2002

Therapy/Procedure

2Activities of Daily Living (ADL)
06/2012 - 11/2011